Interventional Cardiology News and Research

RSS

UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center will unveil its new $800 million hospital at a dedication ceremony today. The 12-floor, 460-bed facility is being hailed as a patient-centered, state-of-the-art medical innovation for the people of Dallas, North Texas, and beyond.

30 Oct 2014

Minimally invasive valve-repair procedures offer hope for patients who have heart-valve problems

Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency. The later turned her life into a battle for breath, eliminating almost all activities and even making sleep a struggle. She couldn't sleep for more than 20-minutes at a time without waking in a fit of coughing. Thanks to a leading-edge procedure performed at UT Southwestern Medical Center, Mrs. Henderson is now breathing - and sleeping - easy.

9 Oct 2014

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

More than 4,000 extra wide seats were made to accommodate Brazil's increasing obese population during the World Cup this year. Obesity affects nearly 20 percent of the population in Brazil and is currently classified as a disability. This and other cardiovascular issues, such as the overuse of technology, will be the focus of the Brazilian Congress of Cardiology, a joint event with the European Society of Cardiology and the Brazilian Society of Cardiology, 26-29 September.

23 Sep 2014

Osprey Medical to release enhanced AVERT Plus System at TCT Meeting

Osprey Medical Inc. has developed a new smart syringe and LCD display system, soon to be incorporated with its existing AVERT System.

16 Sep 2014

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.

2 Sep 2014

Complete revascularisation leads to better outcomes in patients with heart attack

In patients being treated for heart attack, complete revascularisation of all significantly blocked arteries leads to better outcomes compared to a strategy of unblocking just the "culprit" artery responsible for the heart attack, according to a new study presented today at ESC Congress 2014.

1 Sep 2014

Recommendations on arrhythmia management in ACS patients published in EP Europace

The first multidisciplinary recommendations on the management of arrhythmias in patients with acute coronary syndromes (ACS) are published today in EP Europace.

30 Aug 2014

Philips to highlight full range of cardiology solutions at ESC Congress 2014

Royal Philips today announced its presence at the European Society of Cardiology Congress 2014, where the company is highlighting the full range of its cardiology solutions serving clinicians and patients across the care continuum from prevention and diagnosis, to treatment, recovery and wellness.

From Philips Healthcare 29 Aug 2014

Dr. Mark Rasak recognized with Diamond Lifetime Achievement Award in the field of Medicine

Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates.

23 Aug 2014

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Boston Scientific Corporation and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire.

19 Aug 2014

New cholesterol guidelines can significantly help reduce cardiovascular events

A study from UT-Southwestern researchers found that recently introduced cholesterol guidelines would significantly reduce new cardiovascular events, when compared to treatment based on previous cholesterol guidelines.

19 Aug 2014

Study aims at best way to treat deep vein thrombosis

Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers.

22 Jul 2014

Researchers use simple tactics to reduce unnecessary blood tests, health care spending

Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.

2 Jul 2014

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Taxus Cardium Pharmaceuticals Group Inc. will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx Ad5FGF-4, Cardium Therapeutics’ angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.

25 Jun 2014

Study: Use of stem cells to regenerate heart muscle in patients who have heart attacks

Stem cell therapy for cardiovascular disease isn't a medical pipe dream - it's a reality today, although patients need to better understand the complex science behind these experimental treatments, according to the chief of Cardiology for the Cedars-Sinai Heart Institute.

17 Jun 2014

Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

Mount Sinai Heart will host its innovative and prestigious 17th Annual 2014 Live Symposium of Complex Coronary, Valvular, and Vascular Cases June 10-13 at The Mount Sinai Hospital.

31 May 2014

Experts discuss potential advantages of bioresorbable vascular scaffolds at EuroPCR 2014

At EuroPCR 2014 yesterday, experts discussed the development in evidence for bioresorbable vascular scaffolds, which represent an era of vascular restoration in interventional cardiology.

23 May 2014

Argon Medical Devices starts marketing CLEANERXT Rotational Thrombectomy System

Argon Medical Devices, Inc. announced today that the company has begun marketing the CLEANERXT Rotational Thrombectomy System as a new addition to the CLEANER family of dialysis products.

6 May 2014

Cardiac Catheterization Laboratory of Mount Sinai Heart receives highest "two-star" safety rating

The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital has once again received the highest "two-star" safety rating from the New York State Department of Health for its percutaneous coronary interventions (PCI) overall and in non-emergency cases.